Fowl Cholera in Poultry: Etiology, Epidemiology, Clinical Signs, and Control

Introduction

Fowl cholera, also designated avian pasteurellosis, is a contagious bacterial disease affecting domestic poultry, waterfowl, and numerous wild avian species. The condition is caused by the bacterium Pasteurella multocida, a Gram-negative, non-motile, facultatively anaerobic coccobacillus. Fowl cholera is an economically significant disease in commercial poultry production, appearing in peracute, acute, and chronic forms. The clinical presentation and mortality rates vary considerably depending on host species, immune status, environmental stressors, and the virulence of the infecting P. multocida strain. The disease is classified under the World Organisation for Animal Health (WOAH) Terrestrial Animal Health Code. This article explores the etiology, epidemiology, clinical signs, pathology, diagnostic methodologies, treatment options, and control measures for fowl cholera, with a comparative reference to other upper respiratory conditions such as Avian Coryza (Infectious Coryza): Etiology, Clinical Signs, Diagnosis, and Control in Poultry and other bacterial pathogens like Escherichia coli in Avian Colibacillosis: Etiology, Clinical Signs, Diagnosis, and Control in Poultry.

Etiology

Fowl cholera is caused by Pasteurella multocida, a member of the family Pasteurellaceae. The bacterium is a small, pleomorphic, Gram-negative rod that exhibits bipolar staining with Giemsa or Wright stain. P. multocida is classified into five capsular serogroups (A, B, D, E, F) based on capsular polysaccharide antigens, and 16 somatic serotypes identified by lipopolysaccharide (LPS) antigens. The most common serogroups associated with fowl cholera in poultry are capsular type A and, less commonly, type D. Strains belonging to capsular type A and specific somatic serotypes (e.g., 1, 3, 4) are considered highly virulent for avian hosts.

The virulence of P. multocida is multifactorial. Key virulence factors include the polysaccharide capsule, which confers resistance to phagocytosis; lipopolysaccharide (LPS), which induces a strong inflammatory response; adhesins such as filamentous hemagglutinin (FhaB2) and outer membrane proteins (OMPs) that facilitate colonization of the respiratory epithelium; and a sialoprotease that may degrade host immunoglobulin A. Additionally, the bacterium produces a dermonecrotic toxin (PMT) in some serogroups (mainly type D), which contributes to tissue damage. Iron acquisition systems, including siderophore-mediated transporters (e.g., TonB-dependent receptors), enable survival within the host iron-limited environment.

Fowl cholera is caused by which bacteria? The correct answer is Pasteurella multocida. This is a fundamental distinction in clinical microbiology. The disease must be differentiated from Avian Coryza, which is caused by Avibacterium paragallinarum.

Epidemiology

Host Range and Susceptibility

Fowl cholera affects a wide range of avian species. Among domestic poultry, chickens, turkeys, ducks, geese, and other game birds are susceptible. Turkeys are generally considered more susceptible than chickens, often experiencing higher morbidity and mortality during outbreaks. Waterfowl, particularly wild ducks and geese, serve as important reservoirs and can transmit the organism to naive commercial flocks. The organism can also colonize other domestic animals, but fowl cholera is exclusively an avian disease.

Transmission

Transmission of P. multocida occurs horizontally via direct contact between infected and susceptible birds. The primary route of infection is through the respiratory tract via inhalation of aerosolized droplets containing bacteria. Oral transmission through contaminated feed, water, or fomites is also possible. The bacterium can survive for weeks in organic matter, soil, or water, facilitating indirect transmission. Chronically infected carrier birds that shed the organism intermittently are the most significant source of infection within a flock.

Avian Cholera Transmission to Humans

Avian cholera transmission to humans is extremely rare, but it is a recognized zoonotic potential. P. multocida can cause localized wound infections (e.g., cellulitis, abscesses) following bites, scratches, or direct contact with infected secretions. Systemic infections in immunocompromised individuals have been reported, but avian-to-human transmission is not considered a major public health concern. The primary risk is for poultry workers, veterinarians, and abattoir personnel.

Risk Factors

Several factors increase the risk of fowl cholera outbreaks in poultry flocks. These include:

• Stressors: Transport, overcrowding, poor ventilation, nutritional deficiencies, and concurrent infections (e.g., Mycoplasma gallisepticum, coccidiosis).
• Biosecurity failures: Introduction of new birds without quarantine, contaminated equipment or vehicles, and presence of wild birds.
• Environmental conditions: Wet, damp housing; accumulation of organic matter; and poor litter management.

Seasonal Patterns

Fowl cholera outbreaks often exhibit seasonal patterns, with higher incidence during periods of cold, damp weather when respiratory defenses are compromised. Outbreaks are also associated with increased stress during the winter months.

Clinical Signs

The clinical manifestations of fowl cholera depend on the disease form: peracute, acute, or chronic.

Peracute Form

The peracute form is characterized by sudden death in apparently healthy birds with no premonitory signs. Mortality spikes can occur within 24 to 48 hours of initial exposure. This form is more common in turkeys. Affected birds may die in good body condition with full crops.

Acute Form

The acute form is the most clinically apparent presentation. Signs typically appear within 12 to 48 hours after exposure. Key clinical signs include:

• Fever: Elevated body temperature.
• Depression: Lethargy, ruffled feathers, drooping wings, and isolation from the flock.
• Anorexia: Reduced feed intake.
• Respiratory distress: Dyspnea, open-mouth breathing, and increased respiratory rate.
• Ocular and nasal discharge: Serous to mucopurulent exudate from the nares and conjunctivae.
• Cyanosis: Bluish discoloration of the comb, wattles, and facial tissues due to hypoxia and septicemia.
• Diarrhea: Mucoid to hemorrhagic diarrhea, often with a greenish-yellow coloration.
• Torticollis: In some cases, neurological signs such as neck twisting may be observed.

Chronic Form

Chronic fowl cholera is typically a localized infection involving the upper respiratory tract, sinuses, joints, and visceral organs. Birds may present with:

• Facial swelling: Edema of the wattles, comb, and infraorbital sinuses.
• Conjunctivitis: Swollen, red, or exudative conjunctivae.
• Arthritis: Swollen, hot, and painful joints (especially hock and wing joints).
• Torticollis and other neurological signs: Meningitis or inner ear infection can cause abnormal head posture.
• Coughing and sneezing: Persistent respiratory signs.

The differential diagnosis for acute respiratory signs and septicemia includes Avian Influenza A Virus in Poultry: Clinical Signs and Surveillance, Newcastle Disease, and infectious coryza.

Pathology

Gross Lesions

Pathological findings at necropsy reflect the fulminant septicemia typical of the acute disease. Key gross lesions include:

• Petechial hemorrhages: On the heart (epicardium), liver, kidney, and serosal surfaces.
• Liver: Enlarged, friable, and studded with multiple, small (1-2 mm), pale to beige necrotic foci (hepatic necrosis).
• Spleen: Enlarged, mottled, and hemorrhagic.
• Lungs: Congested, edematous, and sometimes with fibrinous exudate.
• Pericarditis: Fibrinous, purulent exudate within the pericardial sac.
• Fibrinous peritonitis: In some birds, there is a fibrinous exudate covering the abdominal viscera.
• Articular lesions: Synovial fluid in affected joints is increased and may contain fibrin clots.

Histopathology

Histological examination reveals:

• Hepatic lesions: Extensive multifocal coagulative necrosis surrounded by a zone of heterophilic infiltration and fibrin deposition.
• Splenic necrosis: Multifocal necrosis of lymphoid follicles and red pulp.
• Lung lesions: Interstitial pneumonia with edema, congestion, and heterophilic infiltration.
• Myocardial necrosis: Petechial hemorrhages correspond to foci of myocardial degeneration and necrosis.
• Meningitis: In cases with neurological signs, there is heterophilic infiltration of the meninges.

Diagnostics

Accurate diagnosis relies on a combination of clinical history, necropsy findings, and laboratory confirmation.

Sample Collection

Appropriate samples include:

• Swabs: Oropharyngeal, choanal cleft, or tracheal swabs in live birds. Post-mortem swabs from the trachea, lungs, bone marrow, and joint fluid.
• Tissue: Liver, spleen, lungs, bone marrow, and affected joints are collected for bacterial culture.
• Whole blood: For acute phase detection via polymerase chain reaction (PCR) or culture.

Bacterial Culture

P. multocida grows on enriched media such as blood agar or chocolate agar, producing characteristic small, dew-drop, mucoid colonies. Bipolar staining can be observed after Gram stain. Growth is enhanced by incubating in an atmosphere of 5-10% CO2 at 37 degrees Celsius for 18-24 hours. Identification is confirmed by colony morphology, Gram stain, and biochemical reactions (catalase positive, oxidase positive, indole positive, and glucose fermentation).

Molecular Diagnostics

PCR assays targeting specific P. multocida genes (e.g., kmt1, hyaD-hyaC, or virulence-associated genes) offer a rapid, sensitive, and specific diagnostic method. Real-time PCR is now the frontline test for detecting carrier birds and confirming clinical cases. Molecular typing techniques such as random amplified polymorphic DNA (RAPD) analysis, restriction endonuclease analysis (REA), or multilocus sequence typing (MLST) are used for epidemiological investigations.

Serology

Serological tests such as enzyme-linked immunosorbent assays (ELISA) can detect antibodies specific to P. multocida capsular or somatic antigens. Serology is primarily used for population-level surveillance and vaccine response monitoring rather than for diagnosing acute disease.

Differential Diagnosis

The clinical presentation of fowl cholera can mimic several other diseases. The key differentials include:

Treatment

Antimicrobial Therapy

Antimicrobial treatment is essential for managing outbreaks. Selection should be based on antibiotic sensitivity testing of the isolated P. multocida strain. Common antimicrobials with demonstrated efficacy include:

• Tetracyclines: Oxytetracycline and chlortetracycline are frequently used in drinking water or feed. Resistance is known to develop.
• Penicillin and beta-lactams: Ampicillin and amoxicillin are often effective.
• Fluoroquinolones: Enrofloxacin, danofloxacin, and other fluoroquinolones are highly effective but should be reserved as a last line due to concerns about antimicrobial resistance.
• Sulfonamides: Trimethoprim-sulfamethoxazole (TMP-SMX) and sulfadimethoxine are used, but resistance is common.
• Macrolides: Tylosin and tilmicosin may be used in some cases.

Treatment is typically administered in the drinking water or in feed for 3-5 days, with a withdrawal period strictly enforced before slaughter. In severe outbreaks, individual bird injections may be necessary.

Supportive Care

Supportive care includes optimizing environmental conditions: reducing stocking density, improving ventilation, providing clean bedding, and ensuring proper nutrition. Vitamin and electrolyte supplementation may support recovery.

Public Health and Zoonotic Concerns

Given the potential for avian cholera transmission to humans, personnel handling infected birds should wear protective gloves and masks. Proper hand hygiene and wound disinfection are essential. Infected poultry that die from fowl cholera should be disposed of safely, typically by incineration or rendering, to prevent environmental contamination and reduce zoonotic risk.

Control and Prevention

Biosecurity

Rigorous biosecurity practices are the cornerstone of fowl cholera prevention. These include:

• Quarantine: All new birds should be isolated for at least two weeks before introduction to an established flock.
• All-in/all-out management: Complete depopulation followed by thorough cleaning and disinfection between groups.
• Disinfection: Effective disinfectants against P. multocida include chlorhexidine, hydrogen peroxide, sodium hypochlorite, and quaternary ammonium compounds. Organic matter must be removed before disinfection.
• Rodent and wild bird control: Wild birds, particularly waterfowl, can introduce P. multocida. Rodent control also reduces the risk.
• Footbaths and vehicle disinfection: Essential for preventing mechanical transmission.

Vaccination

Vaccination is used in high-risk flocks but is not always fully protective due to the antigenic diversity of P. multocida. Two main vaccine types are available:

• Bacterins: Killed whole-cell vaccines (bacterins) are widely used. They stimulate humoral immunity and are protective against homologous serotypes but provide limited cross-protection against heterologous strains.
• Live attenuated vaccines: Live vaccines are available for some serotypes. They induce a more robust cellular and humoral immune response and can provide broader protection. However, they require careful handling to prevent reversion to virulence and are not suitable for all production systems.

Vaccination protocols typically require two doses given 2-4 weeks apart, with annual boosters.

Eradication

Once an outbreak is confirmed, eradication strategies include:

• Depopulation: In severe cases, complete depopulation of the affected barn or unit is recommended.
• Test and cull: In breeder flocks, identification and removal of chronic carrier birds via choanal cleft swabbing and PCR, followed by culling.

Regional and Flock-Level Control

Coordination with local veterinary authorities is essential for managing outbreaks. Movement restrictions on birds and eggs from affected premises are enforced. Flock-level control combines vaccination, biosecurity, antimicrobial therapy, and enhanced monitoring.

Reported Cases and History

Fowl cholera has been reported on all continents where poultry are raised. The disease is enzootic in many wild bird populations, which act as a reservoir. Outbreak investigations historically highlight the role of carrier birds, introduced by mixing populations from different sources.

Fowl Cholera Meaning in Bengali

For regional reference, the fowl cholera meaning in Bengali is "ফাউল কলেরা" (phāula kōlērā), which directly translates to "bird cholera" or "avian cholera." It is also known as "পক্ষী কলেরা" (paksī kōlērā).

Conclusion

Fowl cholera remains a significant infectious disease in poultry production, caused by Pasteurella multocida. The disease can manifest in peracute, acute, or chronic forms, with turkeys and waterfowl particularly vulnerable. Effective control relies on rigorous biosecurity, rapid and accurate laboratory diagnostics, targeted antimicrobial therapy, and strategic vaccination. Understanding the epidemiology, host-pathogen interactions, and zoonotic transmission risk to humans is critical for veterinary practitioners managing both commercial and backyard flocks.

References

Standard clinical references form the basis of this review. No peer-reviewed journal articles were provided in the literature context. Therefore, the following reference list relies on standard textbooks and authoritative compilations.

1. Glisson, J. R., & Hofacre, C. L. (2013). Fowl cholera. In D. E. Swayne, J. R. Glisson, L. R. McDougald, L. K. Nolan, D. L. Suarez, & V. L. Nair (Eds.), Diseases of Poultry (13th ed.). Wiley-Blackwell.

2. United States Department of Agriculture. (2017). Fowl Cholera: Prevention and Control. USDA Animal and Plant Health Inspection Service.

3. World Organisation for Animal Health (OIE). (2019). Chapter 2.4.6. Fowl cholera. In Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (8th ed.). OIE.

4. Merck Veterinary Manual. (2025). Fowl Cholera. Merck & Co., Inc.

5. Hirsh, D. C., & Zee, Y. C. (1999). Veterinary Microbiology. Blackwell Science.

6. Quinn, P. J., Carter, M. E., Markey, B. K., & Carter, G. R. (1994). Clinical Veterinary Microbiology. Wolfe Publishing.

7. Barnes, H. J., Vaillancourt, J.-P., & Gross, W. B. (2003). Fowl cholera. In Y. M. Saif, H. J. Barnes, J. R. Glisson, A. M. Fadly, L. R. McDougald, & D. E. Swayne (Eds.), Diseases of Poultry (11th ed.). Iowa State Press.

8. Calnek, B. W. (Ed.). (1997). Diseases of Poultry (10th ed.). Iowa State University Press.

9. Shivaprasad, H. L. (2000). Pathology of fowl cholera. In Proceedings of the 49th Western Poultry Disease Conference (pp. 10-13). University of California.

10. Benjamin, M. M. (1970). Outline of Veterinary Clinical Pathology. Iowa State University Press.

Disclaimer
This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.